Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta‐analysis

X Mao, KS Cheung, C Peng, LY Mak, HM Cheng… - Hepatology, 2023 - journals.lww.com
Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearan... : Hepatology Steatosis,
HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis …

[HTML][HTML] Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

YJ Wong, VH Nguyen, HI Yang, J Li… - Clinical and …, 2023 - ncbi.nlm.nih.gov
Methods We searched 4 databases from inception to December 2021 and pooled study-
level estimates using a random-effects model for conventional MA. For IPDMA, we evaluated …

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

M Eslam, SK Sarin, VWS Wong, JG Fan… - Hepatology …, 2020 - Springer
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

[PDF][PDF] Nonalcoholic steatohepatitis is associated with liver‐related outcomes and all‐cause mortality in chronic hepatitis B

HSJ Choi, WP Brouwer, WMR Zanjir, RA de Man… - …, 2020 - Wiley Online Library
Background and Aims Chronic hepatitis B (CHB) and nonalcoholic fatty liver disease are
increasingly observed together in clinical practice, and development of nonalcoholic …

Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study

X Wang, S Wu, X Yuan, S Chen, Q Fu… - The Journal of …, 2022 - academic.oup.com
Context Nonalcoholic fatty liver disease (NAFLD) was renamed metabolic dysfunction
associated with fatty liver disease (MAFLD) recently. Objective We aimed to explore the risk …

Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B

J Li, HI Yang, ML Yeh, MH Le, AK Le… - The Journal of …, 2021 - academic.oup.com
Abstract Background Chronic hepatitis B (CHB) and fatty liver (FL) are common, natural
history data on concurrent FL and CHB (FL-CHB) are limited. This study aimed to evaluate …

Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia

M Yang, L Wei - Liver International, 2022 - Wiley Online Library
Hepatitis B virus (HBV) infection and nonalcoholic fatty liver disease (NAFLD) are two major
causes of chronic liver disease (CLD) that can cause liver cirrhosis and hepatocellular …

Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver

MN Kim, K Han, J Yoo, SG Hwang… - Alimentary …, 2022 - Wiley Online Library
Background Population‐based data are lacking regarding whether fatty liver is a risk factor
for hepatocellular carcinoma (HCC) and mortality in patients with chronic viral hepatitis. Aim …

Chronic hepatitis B and non‐alcoholic fatty liver disease: conspirators or competitors?

J Zhang, S Lin, D Jiang, M Li, Y Chen, J Li… - Liver …, 2020 - Wiley Online Library
Despite the widespread use of vaccines and antiviral drugs, approximately 350‐400 million
patients with chronic hepatitis B (CHB) remain worldwide, who carry high risk of cirrhosis …

Epidemiology of non-alcoholic fatty liver disease in Asia

SW Wong, WK Chan - Indian Journal of Gastroenterology, 2020 - Springer
The growing burden of non-alcoholic fatty liver disease (NAFLD) parallels the increasing
prevalence of obesity in Asia. The overall prevalence of NAFLD in Asia is now estimated to …